BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an ...

The second phase of FMCSA's Drug & Alcohol Clearinghouse takes effect Monday, Nov. 18, which requires states to downgrade ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but ...

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer ...

Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl ... U.K. site dubbed “the Nucleus” with Cardinal Health serving as the U.S. commercial distribution partner. The ...

FMCSA Clearinghouse Phase 2 enforcement may impact about 179,000 CDL holders who are in prohibited status for a drug or ...

The Drug & Alcohol Clearinghouse-II regulation requires State Driver Licensing Agencies (SDLAs) to remove commercial driving ...

With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...

A Falconer woman will be headed to prison after admitting to sex trafficking drug addicts, as well as peddling drugs. U.S. Attorney Trini E. Ross has announced that 25-year-old Cora Waddington, ...

An Adelaide Hills personal trainer turned dark web drug dealer has confessed to his crimes in court in front of his family, ...